Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-10

Clinical Trial Update: The Use of Small Bowel Ultrasound to Predict Response to Remicade Induction [NA]

View source ↗

Summary

A completed clinical trial evaluating whether small bowel ultrasound can predict response to Remicade induction in Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remicade (infliximab)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Crohn's Disease | NA | Status: COMPLETED | Results posted: 2019-05-10